Global Implantable Cardioverter Defibrillator (ICD) Market Size, Share, Opportunities, And Trend By Chamber (Single Chambered, Dual Chambered), By Type (Subcutaneous ICD, Transvenous ICD, Cardiac Resynchronization Therapy Defibrillator), By End-User (Hospitals & Clinics, Ambulatory Care Centre), And By Geography - Forecasts From 2025 To 2030

Implantable Cardioverter Defibrillator (ICD) Market Size:

The global implantable cardioverter defibrillators market will grow at a CAGR of 6.00% to be valued at US$6.868 billion in 2030 from US$5.131 billion in 2025.

Implantable Cardioverter Defibrillator (ICD) Market Trends:

An implantable cardioverter defibrillator is an implantable electronic device that is used for treatment in case of sudden cardiac arrest and arrhythmia. The device can be used to detect an abnormal heart rate and to deliver electric shocks if required to the patients. The rapidly increasing geriatric population in many regions across the globe is a major factor responsible for the growth of the implantable cardioverter defibrillators market. According to Forbes, 2019, the number of individuals 65 years and older increased by 33%, from 37.2 to 49.2 million people between 2007 to 2017. The number is further expected to continue rising, doubling to 98 million by 2060. Further, the 85 years and older population are expected to increase by more than 8 million by 2040, which will drive market growth as more patients will require implantable cardioverter defibrillators for their treatment.

In addition, the rising incidence of sudden cardiac arrests due to ventricular arrhythmia or any other reason is spurring the demand for advanced implantable cardioverter defibrillators which can keep a track of the patient’s heartbeat and restore normal heartbeat when an abnormal beating is detected. For instance, according to the British Heart Foundation, 2019, in the United Kingdom, there are over 30,000 out-of-hospital cardiac arrests, a year where emergency medical services attempt to resuscitate the victim. In such situations, implantable cardioverter defibrillators can serve as life-savers, and reduce the number of deaths. 

Furthermore, the continuous improvements in technology will increase the efficiency and reliability of the implantable cardioverter defibrillators, thereby bolstering their adoption by the end-users during the forecast period.

By type, the Transvenous ICD segment is expected to have a dominant market share as it is highly being adopted and used, especially in developing countries, and has a higher acquisition cost.  By end-user, the hospitals and clinics are estimated to hold a significant market share owing to the increasing prevalence of cardiac arrests, across the globe.  Geographically, the European region is projected to hold a notable market share due to higher adoption of ICDs, and increasing awareness among patients regarding the ICDs. The Asia Pacific and North America, are further expected to grow at a high CAGR due to the rise in the geriatric population and the increasing incidence of cardiac arrests in the regions.

Implantable Cardioverter Defibrillator (ICD) Market Growth Factors:

• Increasing incidence of cardiovascular diseases in people.

The number of patients suffering from cardiovascular diseases (CVD) nationwide has been on a stable rise. The constant increase in the numbers is likely to increase the demand for implantable cardioverter defibrillators. According to the American Heart Association, in the United States in 2019, coronary events are expected to occur in about 1,055,000 individuals, including 720,000 new and 335,000 recurrent coronary events. The number of people dying from cardiac arrests, worldwide has been increasing.  According to the World Health Organization, cardiac diseases are the main source of death globally. Around, 17.9 million individuals die due to cardiovascular diseases consistently over the globe, which records roughly 31% of deaths globally. The implantable cardioverter defibrillators can effectively be used to decrease these numbers by providing electric shocks to the patients to revive them. The increasing incidence of cardiovascular diseases and cardiac arrests in people will drive market growth during the forecast period. 

• Increase in the geriatric population.

The increase in the geriatric population across the globe is expected to drive the market growth of implantable cardioverter defibrillators market as the population aged above the age of 65 years is more prone to cardiovascular diseases and cardiac arrests. According to the United Nations, in 2019, the geriatric population was 703 million persons, nationwide. The number of older persons is projected to double to 1.5 billion in 2050, this will fuel the market growth as the number of patients requiring implantable cardioverter defibrillators will spike in the market.

• Competitive Insights.

The market leaders for the global implantable cardioverter defibrillators market consist of Boston Scientific Corporation, Medtronic, PLC, MicroPort Scientific Corporation, LivaNova PLC, and Abbott Laboratories. The key players in the market implement growth strategies such as product launches, mergers, acquisitions, etc. to gain a competitive advantage over their competitors. For Instance, in May 2021, MicroPort Scientific Corporation, a global medical device developer and manufacturer, signed a distribution agreement with Implicity, Inc. to enhance its offerings in the U.S. with Implicitly's cloud-based and AI-driven universal cardiac remote monitoring platform to provide high-value services to healthcare providers.

The implantable cardioverter defibrillator (ICD) market report provides an in-depth analysis of the industry landscape, delivering strategic and executive-level insights backed by data-driven forecasts and analysis. This regularly updated report equips decision-makers with actionable intelligence on current market trends, emerging opportunities, and competitive dynamics. The report explores the demand for ICD devices across various applications, such as bradycardia, tachycardia, and heart failure, and their adoption across different geographies. The latest advancements in ICD technology, including subcutaneous devices and AI-powered monitoring systems, are also analyzed to present a holistic view of the market.

Implantable Cardioverter Defibrillator (ICD) Market Segmentations:

Implantable Cardioverter Defibrillator (ICD) Market Segmentation by product type

The report analyzes the market by product type as below:

• Single-Chamber ICDs
• Dual-Chamber ICDs
• Biventricular ICDs (CRT-D)

Implantable Cardioverter Defibrillator (ICD) Market Segmentation by procedure

The report analyzes the market by procedure as below:

• Transvenous Implantable Cardioverter Defibrillators (TV-ICDs)
• Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)

Implantable Cardioverter Defibrillator (ICD) Market Segmentation by application

The report analyzes the market by application as below:

• Bradycardia
• Tachycardia
• Heart Failure
• Other Applications

Implantable Cardioverter Defibrillator (ICD) Market Segmentation by end user

The report analyzes the market by end-user as below:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers (ASCs)

Implantable Cardioverter Defibrillator (ICD) Market Segmentation by regions:

The study also analysed the implantable cardioverter defibrillator (ICD) market into the following regions, with country level forecasts and analysis as below:

• North America (USA, Canada and Mexico)
• South America (Brazil, Argentina, and Others)
• Europe (Germany, UK, France, Spain, and Others
• Middle East and Africa (Saudi Arabia, UAE, and Others)
• Asia Pacific (China, Japan, India, South Korea, Thailand, Indonesia, and Others)

Implantable Cardioverter Defibrillator (ICD) Market Competitive Landscape:

The implantable cardioverter defibrillator (ICD) market features key players such as Medtronic Plc., Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, MicroPort Scientific Corporation, among others. 

Implantable Cardioverter Defibrillator (ICD) Market Report Coverage:

This report provides extensive coverage as explained in the points below:

• Market size, forecasts, and trends by different product type, with historical revenue data and analysis focusing on key factors driving adoption, current challenges faced by key players, and major growth areas.
• Market size, forecasts, and trends by procedure, with historical revenue data and analysis.
• Market size, forecasts, and trends by application, with historical revenue data and analysis.
• Market size, forecasts, and trends by end-user, with historical revenue data and analysis across various segments.
• The implantable cardioverter defibrillator (ICD) market is also analysed across different regions, with historical data, regional share, attractiveness and opportunity of these solutions in different countries. The growth prospects and key players operating in these markets. The section also dwells on the macro factors, economic scenario and other complementing factors aiding in market growth. 
• Market dynamics: The section details the market growth factors, restraints, and opportunities in the market. The segment also presents complete market scenario with the help of Porter’s five forces model. 
• Competitive Intelligence: A thorough investigation on the competitive structure of the market presented through proprietary vendor matrix model, market share analysis of key players, insights on strategies of key players and recent major developments undertaken by the companies to gain competitive edge. 
• Research methodology: The assumptions and sources which were considered to arrive at the final market estimates. Additionally, how our model is refined to ensure most significant factors are taken into consideration with the proper hypothesis and bottom-up and top-down approaches enhance the reliability of forecasts further strengthening the trustworthiness of the numbers being presented. 

How this report is helpful to you and reasons for purchase?

• The report provides a strategic outlook of the implantable cardioverter defibrillator (ICD) market to the decision-makers, analysts and other stakeholders in the easy to read format for taking informed decisions.
• The charts, tables and figures make it easy for the executives to gain valuable insights while skimming the report. 
• Analyst support through calls and email for timely clarification and incorporating additional requests. 
• Option of presentation or doc format with the estimates file to take care of diverse requirements. 
• 15% FREE customization with all our reports help cater additional requirements with significant cost-savings. 
• Option of purchasing specific segments of the study, including opting for summary reports or just the estimates file. 

Implantable Cardioverter Defibrillator (ICD) Market Scope:

 

Report Metric	Details
Implantable Cardioverter Defibrillator Market Size in 2025	US$5.131 billion
Implantable Cardioverter Defibrillator Market Size in 2030	US$6.868 billion
Growth Rate	CAGR of 6.00%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Billion
Segmentation	Product Type Procedure Application End-User Geography
Geographical Segmentation	North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in the Implantable Cardioverter Defibrillator Market	Medtronic Plc. Abbott Laboratories Boston Scientific Corporation Biotronik SE & Co. KG MicroPort Scientific Corporation
Customization Scope	Free report customization with purchase

 

Our Best-Performing Industry Reports:

• Structural Heart Devices Market
• Heart Transplant Devices Market 
• Heart-lung Machine Market

---

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET BY PRODUCT TYPE

5.1. Introduction

5.2. Single-Chamber ICDs

5.3. Dual-Chamber ICDs

5.4. Biventricular ICDs (CRT-D)

6. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET BY PROCEDURE 

6.1. Introduction

6.2. Transvenous Implantable Cardioverter Defibrillators (TV-ICDs)

6.3. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)

7. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET BY APPLICATION

7.1. Introduction

7.2. Bradycardia

7.3. Tachycardia

7.4. Heart Failure

7.5. Other Applications

8. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET BY END-USER

8.1. Introduction

8.2. Hospitals

8.3. Specialty Clinics

8.4. Ambulatory Surgical Centers (ASCs)

9. MAGNETIC RESONANCE IMAGING SYSTEMS MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. USA

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. United Kingdom

9.4.2. Germany

9.4.3. France

9.4.4. Italy

9.4.5. Spain

9.4.6. Others

9.5. Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Others

9.6. Asia Pacific

9.6.1. China

9.6.2. Japan

9.6.3. India

9.6.4. South Korea

9.6.5. Taiwan

9.6.6. Thailand

9.6.7. Indonesia

9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Medtronic Plc.

11.2. Abbott Laboratories

11.3. Boston Scientific Corporation

11.4. Biotronik SE & Co. KG

11.5. MicroPort Scientific Corporation

11.6. LivaNova PLC 

11.7. Koninklijke Philips N.V. 

11.8. Zoll Medical Corporation 

11.9. Cardiac Science Corporation 

11.10. Nihon Kohden Corporation

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Medtronic Plc.

Abbott Laboratories

Boston Scientific Corporation

Biotronik SE & Co. KG

MicroPort Scientific Corporation

LivaNova PLC 

Koninklijke Philips N.V. 

Zoll Medical Corporation 

Cardiac Science Corporation 

Nihon Kohden Corporation